Clinical Trial Update: Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase II/III randomized trial compared irinotecan-based regimens (irinotecan + 5-FU + leucovorin) versus irinotecan + TS-1 as second-line therapy fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Colorectal Cancer | Phase 2, Phase 3 | Status: COMPLETED